{"count": 7, "results": [{"_id": "34339022", "pmid": 34339022, "title": "The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study.", "journal": "Cardiovasc Toxicol", "authors": ["Rahmanifard M", "Vessal M", "Noorafshan A", "Karbalay-Doust S", "Naseh M"], "date": "2021-11-01T00:00:00Z", "doi": "10.1007/s12012-021-09685-8", "meta_date_publication": "2021 Nov", "meta_volume": "21", "meta_issue": "11", "meta_pages": "936-946", "score": 50268.35, "text_hl": "The Protective Effects of @CHEMICAL_coenzyme_Q10 @CHEMICAL_MESH:C024989 @@@Coenzyme Q10@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ Against @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@Doxorubicin@@@-Induced @<m>DISEASE_Cardiotoxicity</m> @DISEASE_MESH:D066126 @@@Cardiotoxicity@@@ in @SPECIES_10116 @@@Rats@@@: A Stereological and Electrocardiogram Study.", "citations": {"NLM": "Rahmanifard M, Vessal M, Noorafshan A, Karbalay-Doust S, Naseh M. The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study. Cardiovasc Toxicol. 2021 Nov;21(11):936-946. PMID: 34339022", "BibTeX": "@article{34339022, title={The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study.}, author={Rahmanifard M and Vessal M and Noorafshan A and Karbalay-Doust S and Naseh M}, journal={Cardiovasc Toxicol}, volume={21}, number={11}, pages={936-946}}"}}, {"_id": "34582653", "pmid": 34582653, "pmcid": "PMC8850900", "title": "The Role of Lisinopril and Bisoprolol to Prevent Anthracycline Induced Cardiotoxicity in Locally Advanced Breast Cancer Patients", "journal": "Asian Pac J Cancer Prev", "authors": ["Wihandono A", "Azhar Y", "Abdurahman M", "Hidayat S"], "date": "2021-09-01T00:00:00Z", "doi": "10.31557/APJCP.2021.22.9.2847", "meta_date_publication": "2021 Sep 1", "meta_volume": "22", "meta_issue": "9", "meta_pages": "2847-2853", "score": 50266.39, "text_hl": "The Role of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @CHEMICAL_Bisoprolol @CHEMICAL_MESH:D017298 @@@Bisoprolol@@@ to Prevent @CHEMICAL_Anthracyclines @CHEMICAL_MESH:D018943 @@@Anthracycline@@@ Induced @<m>DISEASE_Cardiotoxicity</m> @DISEASE_MESH:D066126 @@@Cardiotoxicity@@@ in Locally Advanced @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@Breast Cancer@@@ Patients", "citations": {"NLM": "Wihandono A, Azhar Y, Abdurahman M, Hidayat S. The Role of Lisinopril and Bisoprolol to Prevent Anthracycline Induced Cardiotoxicity in Locally Advanced Breast Cancer Patients Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2847-2853. PMID: 34582653", "BibTeX": "@article{34582653, title={The Role of Lisinopril and Bisoprolol to Prevent Anthracycline Induced Cardiotoxicity in Locally Advanced Breast Cancer Patients}, author={Wihandono A and Azhar Y and Abdurahman M and Hidayat S}, journal={Asian Pac J Cancer Prev}, volume={22}, number={9}, pages={2847-2853}}"}}, {"_id": "32869692", "pmid": 32869692, "title": "Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.", "journal": "J Oncol Pharm Pract", "authors": ["Farina K", "Kalac M", "Kim S"], "date": "2021-06-01T00:00:00Z", "doi": "10.1177/1078155220953886", "meta_date_publication": "2021 Jun", "meta_volume": "27", "meta_issue": "4", "meta_pages": "1011-1015", "score": 50255.08, "text_hl": "Management of @CHEMICAL_Anthracyclines @CHEMICAL_MESH:D018943 @@@anthracycline@@@ @<m>DISEASE_Cardiotoxicity</m> @DISEASE_MESH:D066126 @@@cardiotoxicity@@@ is similar to @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ management, with data suggesting benefit of using @CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@carvedilol@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Farina K, Kalac M, Kim S. Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma. J Oncol Pharm Pract. 2021 Jun;27(4):1011-1015. PMID: 32869692", "BibTeX": "@article{32869692, title={Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.}, author={Farina K and Kalac M and Kim S}, journal={J Oncol Pharm Pract}, volume={27}, number={4}, pages={1011-1015}}"}}, {"_id": "25131909", "pmid": 25131909, "title": "Effectiveness of the combination therapy with lisinopril, ivabradine and multivitamin supplementation in anthracycline-induced severe cardiotoxicity.", "journal": "Int J Cardiol", "authors": ["de Gregorio C", "Potenza G", "Ferraro G"], "date": "2014-10-20T00:00:00Z", "doi": "10.1016/j.ijcard.2014.07.272", "meta_date_publication": "2014 Oct 20", "meta_volume": "176", "meta_issue": "3", "meta_pages": "1374-6", "score": 50072.375, "text_hl": "Effectiveness of the combination therapy with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_Ivabradine @CHEMICAL_MESH:D000077550 @@@ivabradine@@@ and multivitamin supplementation in @CHEMICAL_Anthracyclines @CHEMICAL_MESH:D018943 @@@anthracycline@@@-induced severe @<m>DISEASE_Cardiotoxicity</m> @DISEASE_MESH:D066126 @@@cardiotoxicity@@@.", "citations": {"NLM": "de Gregorio C, Potenza G, Ferraro G. Effectiveness of the combination therapy with lisinopril, ivabradine and multivitamin supplementation in anthracycline-induced severe cardiotoxicity. Int J Cardiol. 2014 Oct 20;176(3):1374-6. PMID: 25131909", "BibTeX": "@article{25131909, title={Effectiveness of the combination therapy with lisinopril, ivabradine and multivitamin supplementation in anthracycline-induced severe cardiotoxicity.}, author={de Gregorio C and Potenza G and Ferraro G}, journal={Int J Cardiol}, volume={176}, number={3}, pages={1374-6}}"}}, {"_id": "23328120", "pmid": 23328120, "title": "Comparative cardioprotective effects and mechanisms of vitamin E and lisinopril against ischemic reperfusion induced cardiac toxicity.", "journal": "Environ Toxicol Pharmacol", "authors": ["Mohanty IR", "Arya DS", "Dinda A", "Gupta SK"], "date": "2013-03-01T00:00:00Z", "doi": "10.1016/j.etap.2012.12.003", "meta_date_publication": "2013 Mar", "meta_volume": "35", "meta_issue": "2", "meta_pages": "207-17", "score": 50069.67, "text_hl": "Comparative cardioprotective effects and mechanisms of @CHEMICAL_Vitamin_E @CHEMICAL_MESH:D014810 @@@vitamin E@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ against @DISEASE_Brain_Ischemia @DISEASE_MESH:D002545 @@@ischemic@@@ reperfusion induced @<m>DISEASE_Cardiotoxicity</m> @DISEASE_MESH:D066126 @@@cardiac toxicity@@@.", "citations": {"NLM": "Mohanty IR, Arya DS, Dinda A, Gupta SK. Comparative cardioprotective effects and mechanisms of vitamin E and lisinopril against ischemic reperfusion induced cardiac toxicity. Environ Toxicol Pharmacol. 2013 Mar;35(2):207-17. PMID: 23328120", "BibTeX": "@article{23328120, title={Comparative cardioprotective effects and mechanisms of vitamin E and lisinopril against ischemic reperfusion induced cardiac toxicity.}, author={Mohanty IR and Arya DS and Dinda A and Gupta SK}, journal={Environ Toxicol Pharmacol}, volume={35}, number={2}, pages={207-17}}"}}, {"_id": "31171092", "pmid": 31171092, "title": "Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer.", "journal": "J Am Coll Cardiol", "authors": ["Guglin M", "Krischer J", "Tamura R", "Fink A", "Bello-Matricaria L", "McCaskill-Stevens W", "Munster PN"], "date": "2019-06-11T00:00:00Z", "doi": "10.1016/j.jacc.2019.03.495", "meta_date_publication": "2019 Jun 11", "meta_volume": "73", "meta_issue": "22", "meta_pages": "2859-2868", "score": 50066.88, "text_hl": "Randomized Trial of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ Versus @CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@Carvedilol@@@ to Prevent @CHEMICAL_Trastuzumab @CHEMICAL_MESH:D000068878 @@@Trastuzumab@@@ @<m>DISEASE_Cardiotoxicity</m> @DISEASE_MESH:D066126 @@@Cardiotoxicity@@@ in @SPECIES_9606 @@@Patients@@@ With @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@Breast Cancer@@@.", "citations": {"NLM": "Guglin M, Krischer J, Tamura R, Fink A, Bello-Matricaria L, McCaskill-Stevens W, Munster PN. Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer. J Am Coll Cardiol. 2019 Jun 11;73(22):2859-2868. PMID: 31171092", "BibTeX": "@article{31171092, title={Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer.}, author={Guglin M and Krischer J and Tamura R and Fink A and Bello-Matricaria L and McCaskill-Stevens W and Munster PN}, journal={J Am Coll Cardiol}, volume={73}, number={22}, pages={2859-2868}}"}}, {"_id": "28577685", "pmid": 28577685, "title": "Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial.", "journal": "Am Heart J", "authors": ["Guglin M", "Munster P", "Fink A", "Krischer J"], "date": "2017-06-01T00:00:00Z", "doi": "10.1016/j.ahj.2017.03.010", "meta_date_publication": "2017 Jun", "meta_volume": "188", "meta_issue": "", "meta_pages": "87-92", "score": 50064.49, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ or Coreg CR in reducing @<m>DISEASE_Cardiotoxicity</m> @DISEASE_MESH:D066126 @@@cardiotoxicity@@@ in @SPECIES_9606 @@@women@@@ with @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@ receiving @CHEMICAL_Trastuzumab @CHEMICAL_MESH:D000068878 @@@trastuzumab@@@: A rationale and design of a randomized clinical trial.", "citations": {"NLM": "Guglin M, Munster P, Fink A, Krischer J. Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial. Am Heart J. 2017 Jun;188():87-92. PMID: 28577685", "BibTeX": "@article{28577685, title={Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial.}, author={Guglin M and Munster P and Fink A and Krischer J}, journal={Am Heart J}, volume={188}, pages={87-92}}"}}]}